{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:07:43Z","timestamp":1774120063821,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T00:00:00Z","timestamp":1232755200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T00:00:00Z","timestamp":1232755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Intensive insulin therapy (IIT) reduced the incidence of critical illness polyneuropathy and\/or myopathy (CIP\/CIM) and the need for prolonged mechanical ventilation (MV \u2265 14 days) in two randomised controlled trials (RCTs) on the effect of IIT in a surgical intensive care unit (SICU) and medical intensive care unit (MICU). In the present study, we investigated whether these effects are also present in daily clinical practice when IIT is implemented outside of a study protocol.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We retrospectively studied electrophysiological data from patients in the SICU and MICU, performed because of clinical weakness and\/or weaning failure, before and after routine implementation of IIT. CIP\/CIM was diagnosed by abundant spontaneous electrical activity on electromyography. Baseline and outcome variables were compared using Student's t-test, Chi-squared or Mann-Whitney U-test when appropriate. The effect of implementing IIT on CIP\/CIM and prolonged MV was assessed using univariate analysis and multivariate logistic regression analysis (MVLR), correcting for baseline and ICU risk factors.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>IIT significantly lowered mean (\u00b1 standard deviation) blood glucose levels (from 144 \u00b1 20 to 107 \u00b1 10 mg\/dl, p &lt; 0.0001) and significantly reduced the diagnosis of CIP\/CIM in the screened long-stay patients (125\/168 (74.4%) to 220\/452 (48.7%), p &lt; 0.0001). MVLR identified implementing IIT as an independent protective factor (p &lt; 0.0001, odds ratio (OR): 0.25 (95% confidence interval (CI): 0.14 to 0.43)). MVLR confirmed the independent protective effect of IIT on prolonged MV (p = 0.002, OR:0.40 (95% CI: 0.22\u20130.72)). This effect was statistically only partially explained by the reduction in CIP\/CIM.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Implementing IIT in routine daily practice in critically ill patients evoked a similar beneficial effect on neuromuscular function as that observed in two RCTs. IIT significantly improved glycaemic control and significantly and independently reduced the electrophysiological incidence of CIP\/CIM. This reduction partially explained the beneficial effect of IIT on prolonged MV.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/cc7694","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T19:13:26Z","timestamp":1232824406000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study"],"prefix":"10.1186","volume":"13","author":[{"given":"Greet","family":"Hermans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten","family":"Schrooten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Berends","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Bouckaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter","family":"De Vooght","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Robberecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greet Van den","family":"Berghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,24]]},"reference":[{"key":"7127_CR1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/jnnp.49.5.563","volume":"49","author":"CF Bolton","year":"1986","unstructured":"Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ: Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barre syndrome.\n                           J Neurol Neurosurg Psychiatry 1986, 49: 563-573. 10.1136\/jnnp.49.5.563","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7127_CR2","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/1097-4598(200012)23:12<1785::AID-MUS1>3.0.CO;2-J","volume":"23","author":"D Lacomis","year":"2000","unstructured":"Lacomis D, Zochodne DW, Bird SJ: Critical illness myopathy.\n                           Muscle Nerve 2000, 23: 1785-1788. 10.1002\/1097-4598(200012)23:12<1785::AID-MUS1>3.0.CO;2-J","journal-title":"Muscle Nerve"},{"key":"7127_CR3","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0140-6736(96)91074-0","volume":"347","author":"N Latronico","year":"1996","unstructured":"Latronico N, Fenzi F, Recupero D, Guarneri B, Tomelleri G, Tonin P, De Maria G, Antonini L, Rizzuto N, Candiani A: Critical illness myopathy and neuropathy.\n                           Lancet 1996, 347: 1579-1582. 10.1016\/S0140-6736(96)91074-0","journal-title":"Lancet"},{"key":"7127_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00415-005-0654-x","volume":"252","author":"J Bednarik","year":"2005","unstructured":"Bednarik J, Vondracek P, Dusek L, Moravcova E, Cundrle I: Risk factors for critical illness polyneuromyopathy.\n                           J Neurol 2005, 252: 343-351. 10.1007\/s00415-005-0654-x","journal-title":"J Neurol"},{"key":"7127_CR5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0165-5728(99)00252-0","volume":"106","author":"MA de Letter","year":"2000","unstructured":"de Letter MA, van Doorn PA, Savelkoul HF, Laman JD, Schmitz PI, Op de Coul AA, Visser LH, Kros JM, Teepen JL, Meche FG: Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue.\n                           J Neuroimmunol 2000, 106: 206-213. 10.1016\/S0165-5728(99)00252-0","journal-title":"J Neuroimmunol"},{"key":"7127_CR6","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jama.1995.03530150045032","volume":"274","author":"FS Leijten","year":"1995","unstructured":"Leijten FS, Harinck-de Weerd JE, Poortvliet DC, de Weerd AW: The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation.\n                           JAMA 1995, 274: 1221-1225. 10.1001\/jama.274.15.1221","journal-title":"JAMA"},{"key":"7127_CR7","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00134-004-2174-z","volume":"30","author":"B De Jonghe","year":"2004","unstructured":"De Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Brochard L: Does ICU-acquired paresis lengthen weaning from mechanical ventilation?\n                           Intensive Care Med 2004, 30: 1117-1121. 10.1007\/s00134-004-2174-z","journal-title":"Intensive Care Med"},{"key":"7127_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/01.CCM.0000153521.41848.7E","volume":"33","author":"J Garnacho-Montero","year":"2005","unstructured":"Garnacho-Montero J, Amaya-Villar R, Garcia-Garmendia JL, Madrazo-Osuna J, Ortiz-Leyba C: Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients.\n                           Crit Care Med 2005, 33: 349-354. 10.1097\/01.CCM.0000153521.41848.7E","journal-title":"Crit Care Med"},{"key":"7127_CR9","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1164\/rccm.200605-665OC","volume":"175","author":"G Hermans","year":"2007","unstructured":"Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H, Bruyninckx F, Berghe G: Impact of Intensive Insulin Therapy on Neuromuscular Complications and Ventilator-dependency in MICU.\n                           Am J Respir Crit Care Med 2007, 175: 480-489. 10.1164\/rccm.200605-665OC","journal-title":"Am J Respir Crit Care Med"},{"key":"7127_CR10","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1007\/s001340101009","volume":"27","author":"J Garnacho-Montero","year":"2001","unstructured":"Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar A, Garnacho-Montero MC, Moyano-Del-Estad MR: Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients.\n                           Intensive Care Med 2001, 27: 1288-1296. 10.1007\/s001340101009","journal-title":"Intensive Care Med"},{"key":"7127_CR11","first-page":"CD006832","volume-title":"Cochrane Database Syst Rev","author":"G Hermans","year":"2009","unstructured":"Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G: Interventions for preventing critical illness polyneuropathy and critical illness myopathy.\n                           Cochrane Database Syst Rev 2009, CD006832."},{"key":"7127_CR12","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1097\/00003246-200112000-00008","volume":"29","author":"MA de Letter","year":"2001","unstructured":"de Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, Meche FG: Risk factors for the development of polyneuropathy and myopathy in critically ill patients.\n                           Crit Care Med 2001, 29: 2281-2286. 10.1097\/00003246-200112000-00008","journal-title":"Crit Care Med"},{"key":"7127_CR13","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1001\/jama.288.22.2859","volume":"288","author":"B De Jonghe","year":"2002","unstructured":"De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphael JC, Outin H, Bastuji-Garin S: Paresis acquired in the intensive care unit: a prospective multicenter study.\n                           JAMA 2002, 288: 2859-2867. 10.1001\/jama.288.22.2859","journal-title":"JAMA"},{"key":"7127_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1378\/chest.99.1.176","volume":"99","author":"NJ Witt","year":"1991","unstructured":"Witt NJ, Zochodne DW, Bolton CF, Grand'Maison F, Wells G, Young GB, Sibbald WJ: Peripheral nerve function in sepsis and multiple organ failure.\n                           Chest 1991, 99: 176-184. 10.1378\/chest.99.1.176","journal-title":"Chest"},{"key":"7127_CR15","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1212\/01.WNL.0000158442.08857.FC","volume":"64","author":"GVan den Berghe","year":"2005","unstructured":"Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ: Insulin therapy protects the central and peripheral nervous system of intensive care patients.\n                           Neurology 2005, 64: 1348-1353.","journal-title":"Neurology"},{"key":"7127_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1742-7843.2006.pto_293.x","volume":"98","author":"RJ Glynn","year":"2006","unstructured":"Glynn RJ, Schneeweiss S, Sturmer T: Indications for propensity scores and review of their use in pharmacoepidemiology.\n                           Basic Clin Pharmacol Toxicol 2006, 98: 253-259. 10.1111\/j.1742-7843.2006.pto_293.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"7127_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11940-000-0027-9","volume":"2","author":"CF Bolton","year":"2000","unstructured":"Bolton CF, Young GB: Critical Illness Polyneuropathy.\n                           Curr Treat Options Neurol 2000, 2: 489-498. 10.1007\/s11940-000-0027-9","journal-title":"Curr Treat Options Neurol"},{"key":"7127_CR18","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00134-003-1858-0","volume":"29","author":"J Bednarik","year":"2003","unstructured":"Bednarik J, Lukas Z, Vondracek P: Critical illness polyneuromyopathy: the electrophysiological components of a complex entity.\n                           Intensive Care Med 2003, 29: 1505-1514. 10.1007\/s00134-003-1858-0","journal-title":"Intensive Care Med"},{"key":"7127_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/mus.20304","volume":"32","author":"CF Bolton","year":"2005","unstructured":"Bolton CF: Neuromuscular manifestations of critical illness.\n                           Muscle Nerve 2005, 32: 140-163. 10.1002\/mus.20304","journal-title":"Muscle Nerve"},{"key":"7127_CR20","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s001340000586","volume":"26","author":"A Tennila","year":"2000","unstructured":"Tennila A, Salmi T, Pettila V, Roine RO, Varpula T, Takkunen O: Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis.\n                           Intensive Care Med 2000, 26: 1360-1363. 10.1007\/s001340000586","journal-title":"Intensive Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc7694.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc7694\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc7694.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:41:42Z","timestamp":1728304902000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc7694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,24]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,2]]}},"alternative-id":["7127"],"URL":"https:\/\/doi.org\/10.1186\/cc7694","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,24]]},"assertion":[{"value":"24 August 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R5"}}